EXT1 and neoplasm: EXT1, initially having been described as a tumor suppressor before it was referred to as a key enzyme in HS formation and fixed in this role, was shown to suppress a protumorigenic signaling in MV3 melanoma cells with relevance for chemosensitivity, reduced mobility, and reduced coagulability under its activity.